Compugen (CGEN) has released an update.
Compugen Ltd. successfully conducted its 2024 Annual General Meeting of Shareholders on September 12, 2024, with all proposals presented receiving approval from the majority of its shareholders. The details of the meeting were filed with the SEC and are incorporated by reference into the company’s existing Registration Statement. This event marks an important affirmation of shareholder confidence and regulatory compliance for the Israel-based biotech firm.
For further insights into CGEN stock, check out TipRanks’ Stock Analysis page.
